Sign up to save your podcasts
Or
Share Understanding the Growing Syndemic—Opioids, HCV, and HIV
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding the Growing Syndemic—Opioids, HCV, and HIV
CME credits: 0.25
Valid until: 29-10-2020
Claim your CME credit at https://reachmd.com/programs/cme/understanding-the-growing-syndemic-opioids-hcv-and-hiv/10995/
The prevalence of chronic HCV infections among people who have injected drugs in the past 12 months is 39 percent. The demographic shift in HCV from baby boomers (a cohort whose HCV has been largely treated) to younger persons is driven by injection drug use. And on top of that, the current opioid epidemic demands HCV elimination strategies that prioritize this critical population, which is what Drs. Charlene Flash and Don des Jarlais are here to discuss.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 29-10-2020
Claim your CME credit at https://reachmd.com/programs/cme/understanding-the-growing-syndemic-opioids-hcv-and-hiv/10995/
The prevalence of chronic HCV infections among people who have injected drugs in the past 12 months is 39 percent. The demographic shift in HCV from baby boomers (a cohort whose HCV has been largely treated) to younger persons is driven by injection drug use. And on top of that, the current opioid epidemic demands HCV elimination strategies that prioritize this critical population, which is what Drs. Charlene Flash and Don des Jarlais are here to discuss.